Skip to main content
Log in

Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, Turkey

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Serological markers for Chlamydia pneumoniae were investigated by using the microimmunofluorescence (MIF) test in various age and patient groups in a specific area in Turkey. IgG seropositivity to C. pneumoniae was 64.3% and 18.7% in healthy adults and children, respectively. The highest positivity rate (77%) was in the 15–19 age group. Among the groups investigated, serological findings revealed a possible etiological association between C. pneumoniae and the clinical condition in the groups with acute myocardial infarction, atypical pneumoniae and chronic obstructive pulmonary disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Freidank HM, Brauer D. Prevalence of antibodies to Chlamydia pneumoniae TWAR in a group of German medical students. J Infect 1993; 27: 89–93.

    PubMed  Google Scholar 

  2. Karvonen M, Tuomiolehto J, Pitkaniemi J, et al. Chlamydia pneumoniae antibody prevalence in South-Western and Eastern Finland in 1983 and 1987. Int J Epidemiol 1994; 23: 176–184.

    PubMed  Google Scholar 

  3. Kobayashi S, Morishita T, Miyake T, et al. Prevalence of Chlamydia pnenmoniae in Japan. J Infect Dis 1991; 163: 417–418.

    PubMed  Google Scholar 

  4. Marton A, Karoly A, Szalka A. Prevalence of Chlamydia pneumoniae antibodies in Hungary. Eur J Clin Microbiol Infect Dis 1992; 11: 139–142.

    PubMed  Google Scholar 

  5. Sundelöf B, Gnarpe J, Gnarpe H, et al. Chlamydia pneumoniae in Swedish patients. Scand J Infect Dis 1993; 25: 429–433.

    PubMed  Google Scholar 

  6. Van den Abeele AM, Van Renterghem L, Willems K, et al. Prevalence of antibodies to Chlamydia pneumoniae in a Belgian population. J Infect Dis 1992; Suppl 1: 87–90.

    Google Scholar 

  7. Wang SP, Grayston JT. Population prevalence of Chlamydia pneumoniae strain TWAR. In: Bowie WR, Caldwell HD, Jones RP, Mardh PA, Ridgway GL, Schachter J, Walter ES, Ward ME (eds), Chlamydial infections. Proceedings of the seventh international symposium on human chlamydial infections. Cambridge, UK: Cambridge University Press, 1990: 402–405.

    Google Scholar 

  8. Blasi F, Legnani D, Lombardo VM, et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 1993; 6(1): 19–22.

    PubMed  Google Scholar 

  9. Falck, G, Heyman L, Gnarpe J, et al. Chlamydia pneumoniae (TWAR): A common agent in acute bronchitis. Scand J Infect Dis 1994; 26: 179–87.

    PubMed  Google Scholar 

  10. Grayston JT., Aldous MB, Easton A, et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 1993; 168: 1231–1235.

    PubMed  Google Scholar 

  11. Hahn DL, Golubjatnikov R. Asthma and chlamydial infection: A case series. J Fam Pract 1994; 38(6): 589–595.

    PubMed  Google Scholar 

  12. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116: 273–278.

    PubMed  Google Scholar 

  13. Saikku P, Leinonen M, Mattila K, et al. Serologic evidence of an association of novel Chlamydia TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988 (ii): 983–986.

    Article  Google Scholar 

  14. Saikku P, Wang SP, Kleemola M, et al. An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis 1985; 151: 832–839.

    PubMed  Google Scholar 

  15. Wang JH, Liu YC, Cheng DL, et al. Seroprevalence of Chlamydia pneumoniae in Taiwan. Scand J Infect Dis 1993; 25: 565–568.

    PubMed  Google Scholar 

  16. Einarsson S, Sigurdsson HK, Magnusdottir SD, et al. Age specific prevalence of antibodies against Chlamydia pneumoniae in Iceland. Scand J Infect Dis 1994; 26: 393–397.

    PubMed  Google Scholar 

  17. Kleemola M, Saikku P, Visakorpi R, et al. Epidemics of Chlamydia pneumoniae caused by TWAR, a new Chlamydia organism, in military trainees in Finland. J Infect Dis 1988; 157: 230–236.

    PubMed  Google Scholar 

  18. Saikku P. The epidemiology and significance of Chlamydia pneumoniae J Infect 1992; 25: 27–34.

    PubMed  Google Scholar 

  19. Grayston JT. Chlamydia pneumoniae strain TWAR. Chest 1989; 95: 664–669.

    PubMed  Google Scholar 

  20. Linnanmäki E, Leinonen M, Mattila K, et al. Chlamydia pneumoniae-specific circulating immune complex in patient with chronic coronary hearth disease. Circulation 1993; 4: 1130–1134.

    Google Scholar 

  21. Saikku P. Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur Heart J 1993; 14(Suppl K): 62–65.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gencay, M., Dereli, D., Ertem, E. et al. Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, Turkey. Eur J Epidemiol 14, 505–509 (1998). https://doi.org/10.1023/A:1007404315879

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007404315879

Navigation